Providence Capital Advisors »

Immunic shares owned by Providence Capital Advisors

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Providence Capital Advisors from 13F filings

Historical chart of Providence Capital Advisors investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Providence Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Providence Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $11k 682 15.37

More positions owned by Providence Capital Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Palo Alto Networks (PANW)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Bank of America Corporation (BAC)
Qualcomm (QCOM)
Deere & Company (DE)
Prologis (PLD)
Thermo Fisher Scientific (TMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)

View all positions for Providence Capital Advisors

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Jones Hill Capital
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management

View all funds holding Immunic